D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$452M |
| 2 |
Apple
AAPL
|
+$291M |
| 3 |
Schlumberger
SLB
|
+$264M |
| 4 |
Johnson & Johnson
JNJ
|
+$254M |
| 5 |
TJX Companies
TJX
|
+$221M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$313M |
| 2 |
Amazon
AMZN
|
+$307M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$285M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$205M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$194M |
Sector Composition
| 1 | Technology | 16.98% |
| 2 | Healthcare | 12.86% |
| 3 | Financials | 11.44% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCA
1976
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $459K | ﹤0.01% |
15,774
-8,276
| -34% | -$241K |
|
|
CLPR
1977
Clipper Realty
CLPR
$69.8M
| $456K | ﹤0.01% |
+35,596
| New | +$456K |
|
|
AVXS
1978
DELISTED
AveXis, Inc. Common Stock
AVXS
| $456K | ﹤0.01% |
+6,000
| New | +$456K |
|
1979
Washington Trust Bancorp
WASH
$570M
| $455K | ﹤0.01% |
9,239
-3,635
| -28% | -$179K |
|
|
FBM
1980
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $455K | ﹤0.01% |
+28,464
| New | +$455K |
|
1981
HEICO
HEI
$44.1B
| $454K | ﹤0.01% |
12,710
-53,955
| -81% | -$1.93M |
|
1982
Rapid7
RPD
$1.26B
| $451K | ﹤0.01% |
+30,077
| New | +$451K |
|
1983
OR Royalties Inc.
OR
$6.69B
| $450K | ﹤0.01% |
40,585
-66,000
| -62% | -$732K |
|
|
ISBC
1984
DELISTED
Investors Bancorp, Inc.
ISBC
| $450K | ﹤0.01% |
31,260
-22,433
| -42% | -$323K |
|
1985
Sarepta Therapeutics
SRPT
$1.8B
| $449K | ﹤0.01% |
15,178
-14,506
| -49% | -$429K |
|
|
ACGN
1986
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $448K | ﹤0.01% |
1,334
-17
| -1% | -$5.71K |
|
1987
Chefs' Warehouse
CHEF
$2.63B
| $447K | ﹤0.01% |
32,142
-38,826
| -55% | -$540K |
|
1988
QCR Holdings
QCRH
$1.32B
| $446K | ﹤0.01% |
10,523
+3,108
| +42% | +$132K |
|
|
JNCE
1989
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $445K | ﹤0.01% |
+20,240
| New | +$445K |
|
1990
Sandstorm Gold
SAND
$3.4B
| $441K | ﹤0.01% |
102,779
-109,735
| -52% | -$471K |
|
1991
Heron Therapeutics
HRTX
$195M
| $439K | ﹤0.01% |
29,252
+15,132
| +107% | +$227K |
|
1992
Blackrock
BLK
$171B
| $438K | ﹤0.01% |
1,143
-10,901
| -91% | -$4.18M |
|
1993
United Bankshares
UBSI
$5.36B
| $438K | ﹤0.01% |
10,357
-74,063
| -88% | -$3.13M |
|
1994
Park-Ohio Holdings
PKOH
$310M
| $435K | ﹤0.01% |
12,094
+228
| +2% | +$8.2K |
|
1995
Dorman Products
DORM
$4.86B
| $432K | ﹤0.01% |
+5,261
| New | +$432K |
|
1996
Fabrinet
FN
$13.3B
| $432K | ﹤0.01% |
10,276
-25,962
| -72% | -$1.09M |
|
1997
Mizuho Financial
MFG
$83.4B
| $432K | ﹤0.01% |
117,034
-35,094
| -23% | -$130K |
|
1998
Titan Machinery
TITN
$464M
| $432K | ﹤0.01% |
28,165
-21,577
| -43% | -$331K |
|
1999
Thomson Reuters
TRI
$76.8B
| $432K | ﹤0.01% |
8,752
-23,893
| -73% | -$1.18M |
|
2000
Church & Dwight Co
CHD
$22.7B
| $429K | ﹤0.01% |
8,601
-120,204
| -93% | -$6M |
|